1887
  1. Home
  2. Eurosurveillance
  3. Volume 29, Issue 45, 07/Nov/2024
  4. Article
Editorial Open Access
Like 0
Download
Preview this article:
Preview Magnify

There is no abstract available.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.45.2400729
2024-11-07
2024-12-12
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.45.2400729
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/45/eurosurv-29-45-1.html?itemId=/content/10.2807/1560-7917.ES.2024.29.45.2400729&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). WHO fungal priority pathogens list to guide research, development and public health action. Geneva: WHO. 25 Oct 2022. Available from: https://www.who.int/publications/i/item/9789240060241
  2. World Health Organization (WHO). Global research agenda for antimicrobial resistance in human health. Geneva: WHO. 22 Jun 2023. Available from: https://www.who.int/publications/m/item/global-research-agenda-for-antimicrobial-resistance-in-human-health
  3. Kenters N, Kiernan M, Chowdhary A, Denning DW, Pemán J, Saris K, et al. Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting. Int J Antimicrob Agents. 2019;54(4):400-6.  https://doi.org/10.1016/j.ijantimicag.2019.08.013  PMID: 31419480 
  4. Rosa R, Abbo LM, Jimenez A, Carter C, Ruiz M, Gerald W, et al. Effectiveness of a sodium hypochlorite isotonic solution in decolonization of patients with Candida auris: Learnings from a county health care system. Am J Infect Control. 2024;52(5):595-8.  https://doi.org/10.1016/j.ajic.2023.11.008  PMID: 38007101 
  5. Meletiadis J, Siopi M, Spruijtenburg B, Georgiou PC, Kostoula M, Vourli S, et al. Candida auris fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023. Euro Surveill. 2024;29(45):2400128.  https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400128 
  6. Samenwerkingsverband Richtlijnen Infectiepreventie (SRI). Bijzonder resistente micro-organismen (BRMO). [Dutch Collaborative Partnership for Infection Prevention Guidelines (SRI). Multidrug-resistant organisms (MDRO)]. Bilthoven: SRI; 11 Oct 2024. Dutch. Available from: https://www.sri-richtlijnen.nl/brmo
  7. European Centre for Disease Prevention and Control (ECDC). Surveillance Atlas of Infectious Diseases. Stockholm: ECDC. 28 Apr 2023. Available from: https://www.ecdc.europa.eu/en/surveillance-atlas-infectious-diseases
  8. Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56(4):321-5.  https://doi.org/10.1016/j.jhin.2004.01.026  PMID: 15066745 
  9. Overdevest I, Nijs M, Op den Buijs I, van Dommelen L, Fonville J. Optimalisatie van screening op carbapenemase-producerende Enterobacteriaceae. [Screening optimalisation for Carbapenemase-producing Enterobacterales]. Ned Tijdschr Med Microbiol. 2019;272Dutch. Available from: https://www.nvmm.nl/ntmm/artikeloverzicht/juni-2019
  10. Samenwerkingsverband Richtlijnen Infectiepreventie (SRI). Conceptrichtlijn 10 Infectiepreventie Bijzonder Resistente MicroOrganismen (BRMO). [Dutch Collaborative Partnership for Infection Prevention Guidelines (SRI). Concept guideline 10 infection prevention multidrug-resistant organisms (MDRO)]. Bilthoven: SRI. [Accessed: 25 Jul 2024]. Dutch. Available from: https://www.nvmm.nl/media/5032/conceptrichtlijn-infectiepreventie-bijzonder-resistente-micro-organismen-brmo-_def-versie-3.pdf
  11. Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2017;64(2):134-40.  https://doi.org/10.1093/cid/ciw691  PMID: 27988485 
  12. Spruijtenburg B, Ahmad S, Asadzadeh M, Alfouzan W, Al-Obaid I, Mokaddas E, et al. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates. Mycoses. 2023;66(12):1079-86.  https://doi.org/10.1111/myc.13655  PMID: 37712885 
  13. Carolus H, Pierson S, Muñoz JF, Subotić A, Cruz RB, Cuomo CA, et al. Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance. MBio. 2021;12(2):e03333-20.  https://doi.org/10.1128/mBio.03333-20  PMID: 33820824 
  14. Rybak JM, Barker KS, Muñoz JF, Parker JE, Ahmad S, Mokaddas E, et al. In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin Microbiol Infect. 2022;28(6):838-43.  https://doi.org/10.1016/j.cmi.2021.11.024  PMID: 34915074 
  15. Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, et al. Effectiveness of Disinfectants Against Candida auris and Other Candida Species. Infect Control Hosp Epidemiol. 2017;38(10):1240-3.  https://doi.org/10.1017/ice.2017.162  PMID: 28793937 
  16. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, et al. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. J Clin Microbiol. 2017;55(10):2996-3005.  https://doi.org/10.1128/JCM.00921-17  PMID: 28747370 
  17. Daneshnia F, de Almeida Júnior JN, Ilkit M, Lombardi L, Perry AM, Gao M, et al. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lancet Microbe. 2023;4(6):e470-80.  https://doi.org/10.1016/S2666-5247(23)00067-8  PMID: 37121240 
  18. Sansom SE, Gussin GM, Schoeny M, Singh RD, Adil H, Bell P, et al. Rapid Environmental Contamination With Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients. Clin Infect Dis. 2024;78(5):1276-84.  https://doi.org/10.1093/cid/ciad752  PMID: 38059527 
  19. Spruijtenburg B, Nobrega de Almeida Júnior J, Ribeiro FC, Kemmerich KK, Baeta K, Meijer EFJ, et al. Multicenter Candida auris outbreak caused by azole-susceptible clade IV in Pernambuco, Brazil. Mycoses. 2024;67(6):e13752.  https://doi.org/10.1111/myc.13752  PMID: 38880933 
  20. Leonhard SE, Chong GM, Foudraine DE, Bode LGM, Croughs P, Popping S, et al. Proposal for a screening protocol for Candida auris colonization. J Hosp Infect. 2024;146:31-6.  https://doi.org/10.1016/j.jhin.2023.12.019  PMID: 38286238 
  21. Centers for Disease Control and Prevention (CDC). C. auris Screening: Patient Swab Collection. Atlanta: CDC; 24 Apr 2024. Available from: https://www.cdc.gov/candida-auris/hcp/screening-hcp/c-auris-screening-patient-swab-collection-1.html
  22. Spruijtenburg B, Badali H, Abastabar M, Mirhendi H, Khodavaisy S, Sharifisooraki J, et al. Confirmation of fifth Candida auris clade by whole genome sequencing. Emerg Microbes Infect. 2022;11(1):2405-11.  https://doi.org/10.1080/22221751.2022.2125349  PMID: 36154919 
  23. Khan T, Faysal NI, Hossain MM, Mah-E-Muneer S, Haider A, Moon SB, et al. Emergence of the novel sixth Candida auris Clade VI in Bangladesh. Microbiol Spectr. 2024;12(7):e0354023.  https://doi.org/10.1128/spectrum.03540-23  PMID: 38842332 
  24. Meijer EFJ, Voss A, Meis JF. Candida auris: huidige inzichten. [Candida auris: current insights]. Ned Tijdschr Med Microbiol. 2022;302Dutch. Available from: https://www.nvmm.nl/media/4649/19962-061.pdf
  25. Alfouzan W, Ahmad S, Dhar R, Asadzadeh M, Almerdasi N, Abdo NM, et al. Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait. J Fungi (Basel). 2020;6(4):307.  https://doi.org/10.3390/jof6040307  PMID: 33233388 
  26. Hoenigl M, Salmanton-García J, Egger M, Gangneux JP, Bicanic T, Arikan-Akdagli S, et al. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study. Lancet Infect Dis. 2023;23(6):751-61.  https://doi.org/10.1016/S1473-3099(22)00872-6  PMID: 37254300 
  27. Kohlenberg A, Monnet DL, Plachouras D, Candida auris survey collaborative group, Candida auris survey collaborative group includes the following national experts. Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021. Euro Surveill. 2022;27(46):2200846.  https://doi.org/10.2807/1560-7917.ES.2022.27.46.2200846  PMID: 36398575 
  28. Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(1):35.  https://doi.org/10.1186/s13756-016-0132-5  PMID: 27777756 
  29. Taori SK, Khonyongwa K, Hayden I, Athukorala GDA, Letters A, Fife A, et al. Candida auris outbreak: Mortality, interventions and cost of sustaining control. J Infect. 2019;79(6):601-11.  https://doi.org/10.1016/j.jinf.2019.09.007  PMID: 31557493 
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error